节点文献

河南食管癌高发区居民食管癌组织中Survivin蛋白的表达

Survivin expression in esophageal squamous cell carcinoma of patients from Linzhou city, a high-incidence area for esophageal cancer in northern China

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 益新娜王立东宋子博王启鸣李吉林郭花琴高珊珊范宗民周琦

【Author】 YI Xinna 1,2), WANG Lidong 1), SONG Zibo 3), WANG Qiming 1), LI Jilin 4), GUO Huaqin 1), GAO Shanshan 1), FAN Zongmin 1),ZHOU Qi 1) 1)Laboratory for Cancer Research, College of Medicine, Zhengzhou University, Zhengzhou 450052 2)the Second Special Medicine Department,People’ s Hospital of Shaanxi Province,Xi’ an 710068 3)Institute of Medical Genetics, People’ s Hospital of Henan Province, Zhengzhou 450003 4)Department of Pathology, Yaocun Esophageal Cancer Hospital, Linzhou 456592

【机构】 郑州大学医学院癌症研究室河南省人民医院医学遗传学研究所林州市姚村食管癌医院病理科郑州大学医学院癌症研究室 郑州450052陕西省人民医院干二病区西安710068郑州450052郑州450003林州456592郑州450052

【摘要】 目的 :探讨河南食管癌高发区居民食管癌组织中Survivin蛋白表达的变化特征及其与患者预后的关系。方法 :114例食管癌患者均为高发区居民 ,随访 5a以上。手术切除标本采用常规组织病理学方法和免疫组织化学(ABC)法 ,检测Survivin蛋白在癌细胞中的表达。结果 :Survivin胞浆表达为 6 7/ 114 (5 9% ) ;胞核表达为 5 8/ 114(5 1% ) ;胞浆胞核均表达为 2 4 / 114 (2 1% ) ;13/ 114 (11% )没有出现任何形式的Survivin表达。Survivin核表达阳性和阴性组食管癌患者的平均生存时间及 95 %的可信区间分别为 38(32 ,4 5 )个月和 5 7(5 1,6 4 )个月 ,Survivin核表达阳性患者生存期明显小于阴性表达者 (P <0 .0 5 ) ;Survivin胞浆表达组患者的平均生存时间及 95 %的可信区间为 5 0(4 4 ,5 5 )个月 ,与Survivin阴性表达患者生存期间差异无统计学意义 (P >0 .0 5 )。Sperman秩相关分析结果表明Sur vivin核阳性表达与食管癌细胞浸润深度相关 (P <0 .0 5 ) ,多因素Cox模型逐步回归分析结果显示“TNM分期”、“分化程度”和“Survivin核表达”3种因素对患者生存期的影响最大。结论 :Survivin蛋白胞核阳性表达是食管癌患者预后不良的标志 ,可能作为一种独立预后指标 ;Survivin蛋白胞浆表达与食管癌患者的预后无相关性

【Abstract】 Aim: To investigate the expression of Survivin in esophageal squamous cell carcinoma (ESCC) at high-incidence area and its relationship with esophageal cancer prognosis. Methods: A total of 114 cases of ESCC were collected from Linzhou city, and all patients were followed up more than 5 years after surgery. Histopathological analysis and immunohistochemical staining (ABC) were applied to detect the expression of Survivin. Results: Survivin was detected in the cytoplasm in 67/114 (59%) and in the nucleus in 58/114(51%)cases with ESCC; 24/114 (21%) cases demonstrated both nuclear and cytoplasmic staining,and there was no any expression in 14/114(11%) cases. The mean survival periods and 95 confidence interval of those with positive nuclear expression of Survivin and with negative expression were 38 (32, 45) and 52 (45, 59) months, respectively. Patients with positive nuclear expression obviously survived less than those with negative expression, and the difference was significant (P<0.05). The expression of Survivin in cytoplasm showed no correlation with patients prognosis(P>0.05). Itwas shown by stepwise multivariate analysis that differentiation, nuclear expression of Survivin,and TNM staging were the most important factors affecting the prognosis of ESCC (P<0.05). Conclusion: The expression of Survivin protein in nuclear may be an independent prognostic indicator for poor prognosis of ESCC, while the expression in cytoplasm has no relationship with the prognosis of ESCC.

【基金】 国家杰出青年科学基金  3 0 0 2 5 0 16;河南省高校创新人才工程项目
  • 【文献出处】 郑州大学学报(医学版) ,Journal of Zhengzhou University(Science Medical) , 编辑部邮箱 ,2004年06期
  • 【分类号】R735.1
  • 【被引频次】5
  • 【下载频次】107
节点文献中: 

本文链接的文献网络图示:

本文的引文网络